Global Vascular Endothelial Growth Factor B Market Insights and Forecast to 2031

Report ID: 1563986 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Vascular Endothelial Growth Factor B Product Introduction
    1.2 Market by Type
        1.2.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Aflibercept
        1.2.3 Aflibercept Biosimilar
        1.2.4 CSL-346
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Rectal Cancer
        1.3.3 Retinal Vein Occlusion
        1.3.4 Diabetic Nephropathy
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Vascular Endothelial Growth Factor B Sales Estimates and Forecasts 2017-2028
    2.2 Global Vascular Endothelial Growth Factor B Revenue Estimates and Forecasts 2017-2028
    2.3 Global Vascular Endothelial Growth Factor B Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Vascular Endothelial Growth Factor B Sales by Region
        2.4.1 Global Vascular Endothelial Growth Factor B Sales by Region (2017-2022)
        2.4.2 Global Sales Vascular Endothelial Growth Factor B by Region (2023-2028)
    2.5 Global Vascular Endothelial Growth Factor B Revenue by Region
        2.5.1 Global Vascular Endothelial Growth Factor B Revenue by Region (2017-2022)
        2.5.2 Global Vascular Endothelial Growth Factor B Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Vascular Endothelial Growth Factor B Sales by Manufacturers
        3.1.1 Global Top Vascular Endothelial Growth Factor B Manufacturers by Sales (2017-2022)
        3.1.2 Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vascular Endothelial Growth Factor B in 2021
    3.2 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers
        3.2.1 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (2017-2022)
        3.2.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor B Revenue in 2021
    3.3 Global Vascular Endothelial Growth Factor B Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Vascular Endothelial Growth Factor B Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Vascular Endothelial Growth Factor B Sales by Type
        4.1.1 Global Vascular Endothelial Growth Factor B Historical Sales by Type (2017-2022)
        4.1.2 Global Vascular Endothelial Growth Factor B Forecasted Sales by Type (2023-2028)
        4.1.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    4.2 Global Vascular Endothelial Growth Factor B Revenue by Type
        4.2.1 Global Vascular Endothelial Growth Factor B Historical Revenue by Type (2017-2022)
        4.2.2 Global Vascular Endothelial Growth Factor B Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    4.3 Global Vascular Endothelial Growth Factor B Price by Type
        4.3.1 Global Vascular Endothelial Growth Factor B Price by Type (2017-2022)
        4.3.2 Global Vascular Endothelial Growth Factor B Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Vascular Endothelial Growth Factor B Sales by Application
        5.1.1 Global Vascular Endothelial Growth Factor B Historical Sales by Application (2017-2022)
        5.1.2 Global Vascular Endothelial Growth Factor B Forecasted Sales by Application (2023-2028)
        5.1.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    5.2 Global Vascular Endothelial Growth Factor B Revenue by Application
        5.2.1 Global Vascular Endothelial Growth Factor B Historical Revenue by Application (2017-2022)
        5.2.2 Global Vascular Endothelial Growth Factor B Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    5.3 Global Vascular Endothelial Growth Factor B Price by Application
        5.3.1 Global Vascular Endothelial Growth Factor B Price by Application (2017-2022)
        5.3.2 Global Vascular Endothelial Growth Factor B Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Vascular Endothelial Growth Factor B Market Size by Type
        6.1.1 North America Vascular Endothelial Growth Factor B Sales by Type (2017-2028)
        6.1.2 North America Vascular Endothelial Growth Factor B Revenue by Type (2017-2028)
    6.2 North America Vascular Endothelial Growth Factor B Market Size by Application
        6.2.1 North America Vascular Endothelial Growth Factor B Sales by Application (2017-2028)
        6.2.2 North America Vascular Endothelial Growth Factor B Revenue by Application (2017-2028)
    6.3 North America Vascular Endothelial Growth Factor B Market Size by Country
        6.3.1 North America Vascular Endothelial Growth Factor B Sales by Country (2017-2028)
        6.3.2 North America Vascular Endothelial Growth Factor B Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Vascular Endothelial Growth Factor B Market Size by Type
        7.1.1 Europe Vascular Endothelial Growth Factor B Sales by Type (2017-2028)
        7.1.2 Europe Vascular Endothelial Growth Factor B Revenue by Type (2017-2028)
    7.2 Europe Vascular Endothelial Growth Factor B Market Size by Application
        7.2.1 Europe Vascular Endothelial Growth Factor B Sales by Application (2017-2028)
        7.2.2 Europe Vascular Endothelial Growth Factor B Revenue by Application (2017-2028)
    7.3 Europe Vascular Endothelial Growth Factor B Market Size by Country
        7.3.1 Europe Vascular Endothelial Growth Factor B Sales by Country (2017-2028)
        7.3.2 Europe Vascular Endothelial Growth Factor B Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Vascular Endothelial Growth Factor B Market Size by Type
        8.1.1 Asia Pacific Vascular Endothelial Growth Factor B Sales by Type (2017-2028)
        8.1.2 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Type (2017-2028)
    8.2 Asia Pacific Vascular Endothelial Growth Factor B Market Size by Application
        8.2.1 Asia Pacific Vascular Endothelial Growth Factor B Sales by Application (2017-2028)
        8.2.2 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Application (2017-2028)
    8.3 Asia Pacific Vascular Endothelial Growth Factor B Market Size by Region
        8.3.1 Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2017-2028)
        8.3.2 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Vascular Endothelial Growth Factor B Market Size by Type
        9.1.1 Latin America Vascular Endothelial Growth Factor B Sales by Type (2017-2028)
        9.1.2 Latin America Vascular Endothelial Growth Factor B Revenue by Type (2017-2028)
    9.2 Latin America Vascular Endothelial Growth Factor B Market Size by Application
        9.2.1 Latin America Vascular Endothelial Growth Factor B Sales by Application (2017-2028)
        9.2.2 Latin America Vascular Endothelial Growth Factor B Revenue by Application (2017-2028)
    9.3 Latin America Vascular Endothelial Growth Factor B Market Size by Country
        9.3.1 Latin America Vascular Endothelial Growth Factor B Sales by Country (2017-2028)
        9.3.2 Latin America Vascular Endothelial Growth Factor B Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Type
        10.1.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Type (2017-2028)
    10.2 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Application
        10.2.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Application (2017-2028)
    10.3 Middle East and Africa Vascular Endothelial Growth Factor B Market Size by Country
        10.3.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Alteogen Inc
        11.1.1 Alteogen Inc Corporation Information
        11.1.2 Alteogen Inc Overview
        11.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Alteogen Inc Recent Developments
    11.2 CSL Ltd
        11.2.1 CSL Ltd Corporation Information
        11.2.2 CSL Ltd Overview
        11.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CSL Ltd Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CSL Ltd Recent Developments
    11.3 Eli Lilly and Company
        11.3.1 Eli Lilly and Company Corporation Information
        11.3.2 Eli Lilly and Company Overview
        11.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lilly and Company Recent Developments
    11.4 Formycon AG
        11.4.1 Formycon AG Corporation Information
        11.4.2 Formycon AG Overview
        11.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Formycon AG Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Formycon AG Recent Developments
    11.5 Regeneron Pharmaceuticals Inc
        11.5.1 Regeneron Pharmaceuticals Inc Corporation Information
        11.5.2 Regeneron Pharmaceuticals Inc Overview
        11.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Regeneron Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Vascular Endothelial Growth Factor B Industry Chain Analysis
    12.2 Vascular Endothelial Growth Factor B Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Vascular Endothelial Growth Factor B Production Mode & Process
    12.4 Vascular Endothelial Growth Factor B Sales and Marketing
        12.4.1 Vascular Endothelial Growth Factor B Sales Channels
        12.4.2 Vascular Endothelial Growth Factor B Distributors
    12.5 Vascular Endothelial Growth Factor B Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Vascular Endothelial Growth Factor B Industry Trends
    13.2 Vascular Endothelial Growth Factor B Market Drivers
    13.3 Vascular Endothelial Growth Factor B Market Challenges
    13.4 Vascular Endothelial Growth Factor B Market Restraints
14 Key Findings in The Global Vascular Endothelial Growth Factor B Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Aflibercept
    Table 3. Major Manufacturers of Aflibercept Biosimilar
    Table 4. Major Manufacturers of CSL-346
    Table 5. Major Manufacturers of Others
    Table 6. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Vascular Endothelial Growth Factor B Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Vascular Endothelial Growth Factor B Sales by Region (2017-2022) & (K Pcs)
    Table 9. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2017-2022)
    Table 10. Global Vascular Endothelial Growth Factor B Sales by Region (2023-2028) & (K Pcs)
    Table 11. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2023-2028)
    Table 12. Global Vascular Endothelial Growth Factor B Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2017-2022)
    Table 14. Global Vascular Endothelial Growth Factor B Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2023-2028)
    Table 16. Global Vascular Endothelial Growth Factor B Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 17. Global Vascular Endothelial Growth Factor B Sales Share by Manufacturers (2017-2022)
    Table 18. Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2017-2022)
    Table 20. Vascular Endothelial Growth Factor B Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 21. Global Vascular Endothelial Growth Factor B Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Vascular Endothelial Growth Factor B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor B as of 2021)
    Table 23. Vascular Endothelial Growth Factor B Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Vascular Endothelial Growth Factor B Product Offered
    Table 25. Date of Manufacturers Enter into Vascular Endothelial Growth Factor B Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
    Table 28. Global Vascular Endothelial Growth Factor B Sales by Type (2023-2028) & (K Pcs)
    Table 29. Global Vascular Endothelial Growth Factor B Sales Share by Type (2017-2022)
    Table 30. Global Vascular Endothelial Growth Factor B Sales Share by Type (2023-2028)
    Table 31. Global Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Vascular Endothelial Growth Factor B Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Vascular Endothelial Growth Factor B Revenue Share by Type (2017-2022)
    Table 34. Global Vascular Endothelial Growth Factor B Revenue Share by Type (2023-2028)
    Table 35. Vascular Endothelial Growth Factor B Price by Type (2017-2022) & (USD/Pcs)
    Table 36. Global Vascular Endothelial Growth Factor B Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 37. Global Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
    Table 38. Global Vascular Endothelial Growth Factor B Sales by Application (2023-2028) & (K Pcs)
    Table 39. Global Vascular Endothelial Growth Factor B Sales Share by Application (2017-2022)
    Table 40. Global Vascular Endothelial Growth Factor B Sales Share by Application (2023-2028)
    Table 41. Global Vascular Endothelial Growth Factor B Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Vascular Endothelial Growth Factor B Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Vascular Endothelial Growth Factor B Revenue Share by Application (2017-2022)
    Table 44. Global Vascular Endothelial Growth Factor B Revenue Share by Application (2023-2028)
    Table 45. Vascular Endothelial Growth Factor B Price by Application (2017-2022) & (USD/Pcs)
    Table 46. Global Vascular Endothelial Growth Factor B Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 47. North America Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
    Table 48. North America Vascular Endothelial Growth Factor B Sales by Type (2023-2028) & (K Pcs)
    Table 49. North America Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Vascular Endothelial Growth Factor B Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
    Table 52. North America Vascular Endothelial Growth Factor B Sales by Application (2023-2028) & (K Pcs)
    Table 53. North America Vascular Endothelial Growth Factor B Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Vascular Endothelial Growth Factor B Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
    Table 56. North America Vascular Endothelial Growth Factor B Sales by Country (2023-2028) & (K Pcs)
    Table 57. North America Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Vascular Endothelial Growth Factor B Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
    Table 60. Europe Vascular Endothelial Growth Factor B Sales by Type (2023-2028) & (K Pcs)
    Table 61. Europe Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Vascular Endothelial Growth Factor B Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
    Table 64. Europe Vascular Endothelial Growth Factor B Sales by Application (2023-2028) & (K Pcs)
    Table 65. Europe Vascular Endothelial Growth Factor B Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Vascular Endothelial Growth Factor B Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
    Table 68. Europe Vascular Endothelial Growth Factor B Sales by Country (2023-2028) & (K Pcs)
    Table 69. Europe Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Vascular Endothelial Growth Factor B Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
    Table 72. Asia Pacific Vascular Endothelial Growth Factor B Sales by Type (2023-2028) & (K Pcs)
    Table 73. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
    Table 76. Asia Pacific Vascular Endothelial Growth Factor B Sales by Application (2023-2028) & (K Pcs)
    Table 77. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2017-2022) & (K Pcs)
    Table 80. Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2023-2028) & (K Pcs)
    Table 81. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
    Table 84. Latin America Vascular Endothelial Growth Factor B Sales by Type (2023-2028) & (K Pcs)
    Table 85. Latin America Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Vascular Endothelial Growth Factor B Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
    Table 88. Latin America Vascular Endothelial Growth Factor B Sales by Application (2023-2028) & (K Pcs)
    Table 89. Latin America Vascular Endothelial Growth Factor B Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Vascular Endothelial Growth Factor B Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
    Table 92. Latin America Vascular Endothelial Growth Factor B Sales by Country (2023-2028) & (K Pcs)
    Table 93. Latin America Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Vascular Endothelial Growth Factor B Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2017-2022) & (K Pcs)
    Table 96. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2023-2028) & (K Pcs)
    Table 97. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2017-2022) & (K Pcs)
    Table 100. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2023-2028) & (K Pcs)
    Table 101. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2017-2022) & (K Pcs)
    Table 104. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2023-2028) & (K Pcs)
    Table 105. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Alteogen Inc Corporation Information
    Table 108. Alteogen Inc Description and Major Businesses
    Table 109. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Alteogen Inc Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Alteogen Inc Recent Developments
    Table 112. CSL Ltd Corporation Information
    Table 113. CSL Ltd Description and Major Businesses
    Table 114. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. CSL Ltd Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. CSL Ltd Recent Developments
    Table 117. Eli Lilly and Company Corporation Information
    Table 118. Eli Lilly and Company Description and Major Businesses
    Table 119. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Eli Lilly and Company Recent Developments
    Table 122. Formycon AG Corporation Information
    Table 123. Formycon AG Description and Major Businesses
    Table 124. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Formycon AG Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Formycon AG Recent Developments
    Table 127. Regeneron Pharmaceuticals Inc Corporation Information
    Table 128. Regeneron Pharmaceuticals Inc Description and Major Businesses
    Table 129. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 130. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Regeneron Pharmaceuticals Inc Recent Developments
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Vascular Endothelial Growth Factor B Distributors List
    Table 135. Vascular Endothelial Growth Factor B Customers List
    Table 136. Vascular Endothelial Growth Factor B Market Trends
    Table 137. Vascular Endothelial Growth Factor B Market Drivers
    Table 138. Vascular Endothelial Growth Factor B Market Challenges
    Table 139. Vascular Endothelial Growth Factor B Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vascular Endothelial Growth Factor B Product Picture
    Figure 3. Global Vascular Endothelial Growth Factor B Market Share by Type in 2021 & 2028
    Figure 3. Aflibercept Product Picture
    Figure 4. Aflibercept Biosimilar Product Picture
    Figure 5. CSL-346 Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Vascular Endothelial Growth Factor B Market Share by Application in 2021 & 2028
    Figure 8. Rectal Cancer
    Figure 9. Retinal Vein Occlusion
    Figure 10. Diabetic Nephropathy
    Figure 11. Others
    Figure 12. Vascular Endothelial Growth Factor B Report Years Considered
    Figure 13. Global Vascular Endothelial Growth Factor B Sales 2017-2028 (K Pcs)
    Figure 14. Global Vascular Endothelial Growth Factor B Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Vascular Endothelial Growth Factor B Revenue 2017-2028 (US$ Million)
    Figure 16. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2017-2022)
    Figure 18. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2023-2028)
    Figure 19. North America Vascular Endothelial Growth Factor B Sales YoY (2017-2028) & (K Pcs)
    Figure 20. North America Vascular Endothelial Growth Factor B Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Vascular Endothelial Growth Factor B Sales YoY (2017-2028) & (K Pcs)
    Figure 22. Europe Vascular Endothelial Growth Factor B Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Vascular Endothelial Growth Factor B Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Asia-Pacific Vascular Endothelial Growth Factor B Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Vascular Endothelial Growth Factor B Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Latin America Vascular Endothelial Growth Factor B Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Vascular Endothelial Growth Factor B Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Middle East & Africa Vascular Endothelial Growth Factor B Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Vascular Endothelial Growth Factor B Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Vascular Endothelial Growth Factor B in the World: Market Share by Vascular Endothelial Growth Factor B Revenue in 2021
    Figure 31. Global Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    Figure 33. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    Figure 34. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    Figure 35. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    Figure 36. North America Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    Figure 37. North America Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    Figure 38. North America Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    Figure 39. North America Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    Figure 40. North America Vascular Endothelial Growth Factor B Sales Share by Country (2017-2028)
    Figure 41. North America Vascular Endothelial Growth Factor B Revenue Share by Country (2017-2028)
    Figure 42. U.S. Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    Figure 45. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    Figure 47. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Vascular Endothelial Growth Factor B Sales Share by Country (2017-2028)
    Figure 49. Europe Vascular Endothelial Growth Factor B Revenue Share by Country (2017-2028)
    Figure 50. Germany Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 51. France Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Vascular Endothelial Growth Factor B Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Vascular Endothelial Growth Factor B Revenue Share by Region (2017-2028)
    Figure 61. China Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 64. India Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Vascular Endothelial Growth Factor B Sales Share by Country (2017-2028)
    Figure 76. Latin America Vascular Endothelial Growth Factor B Revenue Share by Country (2017-2028)
    Figure 77. Mexico Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Vascular Endothelial Growth Factor B Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Share by Country (2017-2028)
    Figure 86. Turkey Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Vascular Endothelial Growth Factor B Revenue (2017-2028) & (US$ Million)
    Figure 89. Vascular Endothelial Growth Factor B Value Chain
    Figure 90. Vascular Endothelial Growth Factor B Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alteogen Inc
CSL Ltd
Eli Lilly and Company
Formycon AG
Regeneron Pharmaceuticals Inc
Frequently Asked Questions
Vascular Endothelial Growth Factor B report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vascular Endothelial Growth Factor B report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vascular Endothelial Growth Factor B report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports